Payment overview · 2025
General Payments
$60.74
4 reported records · 2 companies
Healthcare provider profile · identity verified
Ravikumar R Peddireddy, MD
Allopathic & Osteopathic Physicians|Internal Medicine · FLINT, MI · NPI 1710989546
Verified facts
What the public records show
CMS Open Payments records show Ravikumar R Peddireddy, MD received $60.74 in general payments during 2025 across 4 reported records.
Novo Nordisk Inc accounted for 76.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 57 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $46.49 | 76.5% | 3 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $14.25 | 23.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $44.47 | 3 |
| Education | $16.27 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $46.49 | 3 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $30.22 | 2 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $14.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 57 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 28 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
57 | 17 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1106 | 324 |
| Levothyroxine Sodium | Levothyroxine Sodium | 952 | 247 |
| Losartan Potassium | Losartan Potassium | 842 | 234 |
| Simvastatin | Simvastatin | 789 | 209 |
| Metoprolol Succinate | Metoprolol Succinate | 559 | 165 |
| Amlodipine Besylate | Amlodipine Besylate | 554 | 185 |
| Metoprolol Tartrate | Metoprolol Tartrate | 497 | 139 |
| Omeprazole | Omeprazole | 444 | 134 |
| Potassium Chloride | Potassium Chloride | 367 | 116 |
| Lisinopril | Lisinopril | 349 | 92 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 347 | 95 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 329 | 110 |
| Metformin Hcl | Metformin Hcl | 323 | 95 |
| Eliquis | Apixaban | 310 | 87 |
| Pravastatin Sodium | Pravastatin Sodium | 306 | 93 |
| Hydralazine Hcl | Hydralazine Hcl | 303 | 86 |
| Glimepiride | Glimepiride | 299 | 78 |
| Pantoprazole Sodium | Pantoprazole Sodium | 295 | 89 |
| Alprazolam | Alprazolam | 270 | 106 |
| Azithromycin | Azithromycin | 269 | 206 |
| Furosemide | Furosemide | 257 | 86 |
| Allopurinol | Allopurinol | 247 | 68 |
| Clopidogrel | Clopidogrel Bisulfate | 242 | 75 |
| Tamsulosin Hcl | Tamsulosin Hcl | 241 | 72 |
| Donepezil Hcl | Donepezil Hcl | 234 | 74 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 231 | 84 |
| Sertraline Hcl | Sertraline Hcl | 214 | 62 |
| Hydrochlorothiazide | Hydrochlorothiazide | 204 | 60 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 197 | 51 |
| Gabapentin | Gabapentin | 187 | 62 |
| Carvedilol | Carvedilol | 164 | 47 |
| Tramadol Hcl | Tramadol Hcl | 145 | 56 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 135 | 49 |
| Metformin Hcl Er | Metformin Hcl | 131 | 40 |
| Lovastatin | Lovastatin | 129 | 37 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 128 | 32 |
| Paroxetine Hcl | Paroxetine Hcl | 126 | 34 |
| Glipizide | Glipizide | 124 | 37 |
| Zolpidem Tartrate | Zolpidem Tartrate | 122 | 23 |
| Januvia | Sitagliptin Phosphate | 120 | 25 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 119 | 35 |
| Spironolactone | Spironolactone | 116 | 35 |
| Nifedipine Er | Nifedipine | 107 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 92 | 29 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 89 | 22 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 87 | 22 |
| Enalapril Maleate | Enalapril Maleate | 86 | 21 |
| Famotidine | Famotidine | 84 | 28 |
| Atenolol | Atenolol | 83 | 23 |
| Prednisone | Prednisone | 83 | 52 |
| Trazodone Hcl | Trazodone Hcl | 79 | 26 |
| Warfarin Sodium | Warfarin Sodium | 77 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 76 | 58 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 76 | 21 |
| Alendronate Sodium | Alendronate Sodium | 74 | 20 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 74 | 14 |
| Montelukast Sodium | Montelukast Sodium | 73 | 20 |
| Meclizine Hcl | Meclizine Hcl | 70 | 37 |
| Finasteride | Finasteride | 69 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 68 | 24 |
| Ibuprofen | Ibuprofen | 68 | 29 |
| Methylprednisolone | Methylprednisolone | 66 | 57 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 66 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 19 |
| Clonidine Hcl | Clonidine Hcl | 63 | 20 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 62 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 60 | 47 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 59 | 27 |
| Buspirone Hcl | Buspirone Hcl | 57 | 17 |
| Ozempic | Semaglutide | 57 | 17 |
| Xarelto | Rivaroxaban | 57 | 19 |
| Tizanidine Hcl | Tizanidine Hcl | 55 | 24 |
| Memantine Hcl | Memantine Hcl | 52 | 14 |
| Telmisartan | Telmisartan | 52 | 14 |
| Amiodarone Hcl | Amiodarone Hcl | 50 | 20 |
| Chlorthalidone | Chlorthalidone | 49 | 13 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 49 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 49 | 12 |
| Bumetanide | Bumetanide | 48 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 48 | 41 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 13 |
| Jardiance | Empagliflozin | 48 | 18 |
| Meloxicam | Meloxicam | 47 | 23 |
| Calcitriol | Calcitriol | 46 | 14 |
| Levetiracetam | Levetiracetam | 46 | 12 |
| Trulicity | Dulaglutide | 46 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 45 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 45 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 43 | 17 |
| Raloxifene Hcl | Raloxifene Hcl | 43 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 43 | 34 |
| Ezetimibe | Ezetimibe | 41 | 13 |
| Glipizide Er | Glipizide | 41 | suppressed |
| Dexamethasone | Dexamethasone | 40 | 40 |
| Doxycycline Hyclate | Doxycycline Hyclate | 39 | 34 |
| Nitroglycerin | Nitroglycerin | 39 | 19 |
| Torsemide | Torsemide | 38 | 15 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 37 | 11 |
| Entresto | Sacubitril/Valsartan | 37 | 12 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 37 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 36 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 36 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 36 | 17 |
| Fluticasone Propionate | Fluticasone Propionate | 35 | 17 |
| Mirtazapine | Mirtazapine | 35 | 18 |
| Tresiba Flextouch U-100 | Insulin Degludec | 35 | suppressed |
| Colchicine | Colchicine | 34 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 33 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 33 | 20 |
| Baclofen | Baclofen | 32 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 32 | suppressed |
| Irbesartan | Irbesartan | 32 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | 18 |
| Bupropion Xl | Bupropion Hcl | 31 | 12 |
| Digoxin | Digoxin | 31 | suppressed |
| Cilostazol | Cilostazol | 30 | suppressed |
| Diazepam | Diazepam | 30 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 28 | suppressed |
| Glyburide | Glyburide | 28 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 28 | 11 |
| Rybelsus | Semaglutide | 28 | suppressed |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 28 | suppressed |
| Celecoxib | Celecoxib | 27 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | 12 |
| Sotalol | Sotalol Hcl | 27 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 26 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 26 | 16 |
| Ramipril | Ramipril | 26 | suppressed |
| Lorazepam | Lorazepam | 25 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 25 | 13 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | 11 |
| Cephalexin | Cephalexin | 24 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Levofloxacin | Levofloxacin | 24 | 20 |
| Dulera | Mometasone/Formoterol | 23 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 22 | suppressed |
| Clonazepam | Clonazepam | 22 | suppressed |
| Timolol Maleate | Timolol Maleate | 22 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 22 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Nabumetone | Nabumetone | 21 | suppressed |
| Clonidine | Clonidine | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 20 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Lamotrigine | Lamotrigine | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | 15 |
| Propranolol Hcl Er | Propranolol Hcl | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 16 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 16 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 16 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Carbamazepine | Carbamazepine | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Etodolac | Etodolac | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Lumigan | Bimatoprost | 13 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Metformin Er Osmotic | Metformin Hcl | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Tobramycin | Tobramycin | 12 | 12 |
| Tresiba Flextouch U-200 | Insulin Degludec | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 11 | suppressed |
| Niacin Er | Niacin | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $60.74 · 4 records | Novo Nordisk Inc | Ozempic, Rybelsus, The Cologuard Plus Collection Kit | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error